401 related articles for article (PubMed ID: 22709421)
61. Optic pathway gliomas in children with and without neurofibromatosis 1.
Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA
J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652
[TBL] [Abstract][Full Text] [Related]
62. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.
de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA
J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346
[TBL] [Abstract][Full Text] [Related]
63. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
Wolsey DH; Larson SA; Creel D; Hoffman R
J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
[TBL] [Abstract][Full Text] [Related]
64. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK
J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602
[TBL] [Abstract][Full Text] [Related]
65. Predicting which NF1 optic pathway gliomas will require treatment.
Listernick R
Neurology; 2016 Dec; 87(23):2389-2390. PubMed ID: 27815404
[No Abstract] [Full Text] [Related]
66. Myopia associated with optic nerve gliomas in neurofibromatosis type 1.
de Alba Campomanes AG; Avery RA; Prasad S; Liu GT
J AAPOS; 2012 Feb; 16(1):89-91. PubMed ID: 22370674
[TBL] [Abstract][Full Text] [Related]
67. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
Falzon K; Drimtzias E; Picton S; Simmons I
Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
[TBL] [Abstract][Full Text] [Related]
68. Causes of loss of vision in congenital glaucoma.
Morin JD; Bryars JH
Arch Ophthalmol; 1980 Sep; 98(9):1575-6. PubMed ID: 7425918
[TBL] [Abstract][Full Text] [Related]
69. Optic pathway glioma of childhood.
Rasool N; Odel JG; Kazim M
Curr Opin Ophthalmol; 2017 May; 28(3):289-295. PubMed ID: 28257299
[TBL] [Abstract][Full Text] [Related]
70. Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas.
Avery RA; Dombi E; Hutcheson KA; Acosta MT; Baldwin AM; Madigan WP; Gillespie A; Fitzgibbon EJ; Packer RJ; Widemann BC
Am J Ophthalmol; 2013 Jun; 155(6):1089-1094.e1. PubMed ID: 23453281
[TBL] [Abstract][Full Text] [Related]
71. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
[TBL] [Abstract][Full Text] [Related]
72. Validation of an automated tractography method for the optic radiations as a biomarker of visual acuity in neurofibromatosis-associated optic pathway glioma.
de Blank P; Fisher MJ; Gittleman H; Barnholtz-Sloan JS; Badve C; Berman JI
Exp Neurol; 2018 Jan; 299(Pt B):308-316. PubMed ID: 28587872
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of All Causes of Visual Function Loss in Children With Congenital Blepharoptosis.
Ural O; Mocan MC; Erdener U
J Pediatr Ophthalmol Strabismus; 2020 Mar; 57(2):97-102. PubMed ID: 32203593
[TBL] [Abstract][Full Text] [Related]
74. Vision disorders in public health.
Kleinstein RN
Annu Rev Public Health; 1984; 5():369-84. PubMed ID: 6372815
[No Abstract] [Full Text] [Related]
75. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
Listernick R; Ferner RE; Liu GT; Gutmann DH
Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725
[TBL] [Abstract][Full Text] [Related]
76. Increased prevalence of ametropia in children with neurofibromatosis type 1 disease.
Dotan G; Keren S; Stolovitch C; Toledano-Alhadef H; Kesler A
J Child Neurol; 2015 Jan; 30(1):113-6. PubMed ID: 24659732
[TBL] [Abstract][Full Text] [Related]
77. Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature.
Piccirilli M; Lenzi J; Delfinis C; Trasimeni G; Salvati M; Raco A
Childs Nerv Syst; 2006 Oct; 22(10):1332-7. PubMed ID: 16639629
[TBL] [Abstract][Full Text] [Related]
78. Vision specific quality of life in children with optic pathway gliomas.
Avery RA; Hardy KK
J Neurooncol; 2014 Jan; 116(2):341-7. PubMed ID: 24197987
[TBL] [Abstract][Full Text] [Related]
79. Prevalence and causes of visual impairment in craniosynostotic syndromes.
Tay T; Martin F; Rowe N; Johnson K; Poole M; Tan K; Kennedy I; Gianoutsos M
Clin Exp Ophthalmol; 2006 Jul; 34(5):434-40. PubMed ID: 16872339
[TBL] [Abstract][Full Text] [Related]
80. [A follow-up of patients with anterior optic tract glioma concurrent with type 1 neurofibromatosis].
Serova NK; Lazareva LA; Gorelychev SK; Ozerova VI; Pronin IN
Vestn Oftalmol; 2006; 122(6):39-42. PubMed ID: 17217202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
